Literature DB >> 26810226

Essential Role for Survivin in the Proliferative Expansion of Progenitor and Mature B Cells.

Ana V Miletic1, Julia Jellusova1, Matthew H Cato1, Charlotte R Lee1, Gisele V Baracho1, Edward M Conway2, Robert C Rickert3.   

Abstract

Survivin is a member of the inhibitor of apoptosis family of proteins and a biomarker of poor prognosis in aggressive B cell non-Hodgkin's lymphoma. In addition to its role in inhibition of apoptosis, survivin also regulates mitosis. In this article, we show that deletion of survivin during early B cell development results in a complete block at the cycling pre-B stage. In the periphery, B cell homeostasis is not affected, but survivin-deficient B cells are unable to mount humoral responses. Correspondingly, we show that survivin is required for cell division in response to mitogenic stimulation. Thus, survivin is essential for proliferation of B cell progenitors and activated mature B cells, but is dispensable for B cell survival. Moreover, a small-molecule inhibitor of survivin strongly impaired the growth of representative B lymphoma lines in vitro, supporting the validity of survivin as an attractive therapeutic target for high-grade B cell non-Hodgkin's lymphoma.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26810226      PMCID: PMC4761464          DOI: 10.4049/jimmunol.1501690

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7.

Authors:  S Shin; B J Sung; Y S Cho; H J Kim; N C Ha; J I Hwang; C W Chung; Y K Jung; B H Oh
Journal:  Biochemistry       Date:  2001-01-30       Impact factor: 3.162

2.  Expression of survivin and its relationship to loss of apoptosis in breast carcinomas.

Authors:  K Tanaka; S Iwamoto; G Gon; T Nohara; M Iwamoto; N Tanigawa
Journal:  Clin Cancer Res       Date:  2000-01       Impact factor: 12.531

3.  Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer.

Authors:  Manfred Kraus; Marat B Alimzhanov; Nikolaus Rajewsky; Klaus Rajewsky
Journal:  Cell       Date:  2004-06-11       Impact factor: 41.582

Review 4.  H2AX: the histone guardian of the genome.

Authors:  Oscar Fernandez-Capetillo; Alicia Lee; Michel Nussenzweig; André Nussenzweig
Journal:  DNA Repair (Amst)       Date:  2004 Aug-Sep

5.  Influences on the lifespan of B cell subpopulations defined by different phenotypes.

Authors:  D A Fulcher; A Basten
Journal:  Eur J Immunol       Date:  1997-05       Impact factor: 5.532

Review 6.  The generation of antibody-secreting plasma cells.

Authors:  Stephen L Nutt; Philip D Hodgkin; David M Tarlinton; Lynn M Corcoran
Journal:  Nat Rev Immunol       Date:  2015-02-20       Impact factor: 53.106

7.  Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors.

Authors:  Li Sui; Youyi Dong; Masayuki Ohno; Yasuo Watanabe; Katsuyoshi Sugimoto; Masaaki Tokuda
Journal:  Int J Oncol       Date:  2002-08       Impact factor: 5.650

8.  Human survivin is a kinetochore-associated passenger protein.

Authors:  D A Skoufias; C Mollinari; F B Lacroix; R L Margolis
Journal:  J Cell Biol       Date:  2000-12-25       Impact factor: 10.539

9.  Essential role of survivin, an inhibitor of apoptosis protein, in T cell development, maturation, and homeostasis.

Authors:  Zheng Xing; Edward M Conway; Chulho Kang; Astar Winoto
Journal:  J Exp Med       Date:  2003-12-29       Impact factor: 14.307

10.  H2AX is required for recombination between immunoglobulin switch regions but not for intra-switch region recombination or somatic hypermutation.

Authors:  Bernardo Reina-San-Martin; Simone Difilippantonio; Leif Hanitsch; Revati F Masilamani; Andre Nussenzweig; Michel C Nussenzweig
Journal:  J Exp Med       Date:  2003-06-16       Impact factor: 14.307

View more
  6 in total

1.  New Methods To Analyze B Cell Immune Responses to Thymus-Dependent Antigen Sheep Red Blood Cells.

Authors:  Ellen J McAllister; John R Apgar; Charlotte R Leung; Robert C Rickert; Julia Jellusova
Journal:  J Immunol       Date:  2017-09-15       Impact factor: 5.422

2.  Prolactin Rescues Immature B Cells from Apoptosis-Induced BCR-Aggregation through STAT3, Bcl2a1a, Bcl2l2, and Birc5 in Lupus-Prone MRL/lpr Mice.

Authors:  Rocio Flores-Fernández; Angélica Aponte-López; Mayra C Suárez-Arriaga; Patricia Gorocica-Rosete; Alberto Pizaña-Venegas; Luis Chávez-Sanchéz; Francico Blanco-Favela; Ezequiel M Fuentes-Pananá; Adriana K Chávez-Rueda
Journal:  Cells       Date:  2021-02-04       Impact factor: 6.600

Review 3.  Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies.

Authors:  Navid Shomali; Marwah Suliman Maashi; Behzad Baradaran; Amin Daei Sorkhabi; Aila Sarkesh; Hamed Mohammadi; Maryam Hemmatzadeh; Faroogh Marofi; Siamak Sandoghchian Shotorbani; Mostafa Jarahian
Journal:  Front Immunol       Date:  2022-03-03       Impact factor: 7.561

4.  Postmitotic G1 phase survivin drives mitogen-independent cell division of B lymphocytes.

Authors:  Amit Singh; Matthew H Spitzer; Jaimy P Joy; Mary Kaileh; Xiang Qiu; Garry P Nolan; Ranjan Sen
Journal:  Proc Natl Acad Sci U S A       Date:  2022-04-27       Impact factor: 12.779

Review 5.  Survivin: a unique target for tumor therapy.

Authors:  Himani Garg; Prerna Suri; Jagdish C Gupta; G P Talwar; Shweta Dubey
Journal:  Cancer Cell Int       Date:  2016-06-23       Impact factor: 5.722

Review 6.  Antiapoptotic Molecule Survivin in Transplantation: Helpful or Harmful?

Authors:  Sara Assadiasl; Mohammad Javad Mousavi; Aliakbar Amirzargar
Journal:  J Transplant       Date:  2018-10-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.